An Advance Beneficiary Notice (ABN) must be obtained when it is determined that the laboratory testing / service(s) is likely to not be covered by Medicare. It is necessary to explain to the patient before the start of care that Medicare is likely to deny payment for the laboratory testing / service(s) and the reasons for non-coverage must be indicated. The ABN is used for notifying the patient of non-coverage.
Under current Medicare law, MUSC Laboratory Services is allowed to bill the patient for claims that are denied by Medicare if the ABN is completed prior to the time of specimen collection. Available on this webpage is the current price list for patient billing, should Medicare deny payment.